我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
1
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1995
已完成
100.0%
暂无批准数据
- IXICO PLC has appointed Tanya Voloshen as its first chief commercial officer to strengthen commercial capabilities and accelerate business development activities. - Voloshen will be based in Boston, Massachusetts, to help broaden IXICO's footprint in the US market for neuroscience imaging services. - The new CCO brings extensive commercial leadership experience from neuroscience and medical imaging companies including Perceptive Inc, Clario, QMENTA and ConcertAI. - The appointment reflects IXICO's commitment to growth in the clinical imaging market through its specialized neuroscience imaging and biomarker analytics platform.